vs
Orthofix Medical Inc.（OFIX）与OneStream, Inc.（OS）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是OneStream, Inc.的1.3倍（$219.9M vs $163.7M），OneStream, Inc.净利率更高（0.6% vs -1.0%，领先1.6%），OneStream, Inc.同比增速更快（23.6% vs 2.0%），OneStream, Inc.自由现金流更多（$25.6M vs $16.8M），过去两年OneStream, Inc.的营收复合增速更高（21.8% vs 8.0%）
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
Blue Stream面向美国佛罗里达州科勒尔斯普林斯、韦斯顿两地的居民及商业客户，提供有线电视、有线固话、数字录像服务，以及最高速率达1G的宽带互联网接入服务，深耕当地通信市场，为用户提供稳定可靠的多元通信解决方案。
OFIX vs OS — 直观对比
营收规模更大
OFIX
是对方的1.3倍
$163.7M
营收增速更快
OS
高出21.6%
2.0%
净利率更高
OS
高出1.6%
-1.0%
自由现金流更多
OS
多$8.8M
$16.8M
两年增速更快
OS
近两年复合增速
8.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $219.9M | $163.7M |
| 净利润 | $-2.2M | $999.0K |
| 毛利率 | 71.1% | 69.8% |
| 营业利润率 | 0.2% | -3.2% |
| 净利率 | -1.0% | 0.6% |
| 营收同比 | 2.0% | 23.6% |
| 净利润同比 | 92.4% | — |
| 每股收益（稀释后） | $-0.05 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OFIXOS
| Q4 25 | $219.9M | $163.7M | ||
| Q3 25 | $205.6M | $154.3M | ||
| Q2 25 | $203.1M | $147.6M | ||
| Q1 25 | $193.6M | $136.3M | ||
| Q4 24 | $215.7M | $132.5M | ||
| Q3 24 | $196.6M | $129.1M | ||
| Q2 24 | $198.6M | $117.5M | ||
| Q1 24 | $188.6M | $110.3M |
净利润OFIXOS
| Q4 25 | $-2.2M | $999.0K | ||
| Q3 25 | $-22.8M | $-8.8M | ||
| Q2 25 | $-14.1M | $-18.4M | ||
| Q1 25 | $-53.1M | $-24.0M | ||
| Q4 24 | $-29.1M | — | ||
| Q3 24 | $-27.4M | $-171.9M | ||
| Q2 24 | $-33.4M | $-7.8M | ||
| Q1 24 | $-36.0M | $-5.0M |
毛利率OFIXOS
| Q4 25 | 71.1% | 69.8% | ||
| Q3 25 | 72.2% | 68.1% | ||
| Q2 25 | 68.7% | 68.6% | ||
| Q1 25 | 62.8% | 68.0% | ||
| Q4 24 | 69.0% | 66.8% | ||
| Q3 24 | 68.7% | 50.1% | ||
| Q2 24 | 67.8% | 68.5% | ||
| Q1 24 | 67.5% | 69.1% |
营业利润率OFIXOS
| Q4 25 | 0.2% | -3.2% | ||
| Q3 25 | -8.3% | -11.3% | ||
| Q2 25 | -7.9% | -21.8% | ||
| Q1 25 | -25.2% | -29.3% | ||
| Q4 24 | -5.3% | -35.8% | ||
| Q3 24 | -9.6% | -197.6% | ||
| Q2 24 | -12.5% | -9.8% | ||
| Q1 24 | -15.6% | -4.9% |
净利率OFIXOS
| Q4 25 | -1.0% | 0.6% | ||
| Q3 25 | -11.1% | -5.7% | ||
| Q2 25 | -6.9% | -12.5% | ||
| Q1 25 | -27.4% | -17.6% | ||
| Q4 24 | -13.5% | — | ||
| Q3 24 | -13.9% | -133.1% | ||
| Q2 24 | -16.8% | -6.7% | ||
| Q1 24 | -19.1% | -4.5% |
每股收益（稀释后）OFIXOS
| Q4 25 | $-0.05 | — | ||
| Q3 25 | $-0.57 | — | ||
| Q2 25 | $-0.36 | — | ||
| Q1 25 | $-1.35 | — | ||
| Q4 24 | $-0.76 | — | ||
| Q3 24 | $-0.71 | $-1.06 | ||
| Q2 24 | $-0.88 | — | ||
| Q1 24 | $-0.95 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $82.0M | $693.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $450.0M | $504.7M |
| 总资产 | $850.6M | $1.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资OFIXOS
| Q4 25 | $82.0M | $693.6M | ||
| Q3 25 | $62.9M | $653.9M | ||
| Q2 25 | $65.6M | $652.1M | ||
| Q1 25 | $58.0M | $593.9M | ||
| Q4 24 | $83.2M | $544.2M | ||
| Q3 24 | $30.1M | $495.5M | ||
| Q2 24 | $26.4M | $140.5M | ||
| Q1 24 | $27.0M | — |
总债务OFIXOS
| Q4 25 | — | — | ||
| Q3 25 | $157.2M | — | ||
| Q2 25 | $157.0M | — | ||
| Q1 25 | $156.9M | — | ||
| Q4 24 | $157.0M | — | ||
| Q3 24 | $118.5M | — | ||
| Q2 24 | $118.0M | — | ||
| Q1 24 | $118.2M | — |
股东权益OFIXOS
| Q4 25 | $450.0M | $504.7M | ||
| Q3 25 | $442.5M | $472.1M | ||
| Q2 25 | $458.3M | $458.2M | ||
| Q1 25 | $458.3M | $412.9M | ||
| Q4 24 | $503.1M | $386.2M | ||
| Q3 24 | $525.9M | $458.2M | ||
| Q2 24 | $546.0M | $97.5M | ||
| Q1 24 | $570.3M | $102.5M |
总资产OFIXOS
| Q4 25 | $850.6M | $1.0B | ||
| Q3 25 | $832.6M | $949.4M | ||
| Q2 25 | $837.2M | $910.5M | ||
| Q1 25 | $823.1M | $867.3M | ||
| Q4 24 | $893.3M | $823.2M | ||
| Q3 24 | $867.9M | $750.1M | ||
| Q2 24 | $882.0M | $379.7M | ||
| Q1 24 | $906.0M | — |
负债/权益比OFIXOS
| Q4 25 | — | — | ||
| Q3 25 | 0.36× | — | ||
| Q2 25 | 0.34× | — | ||
| Q1 25 | 0.34× | — | ||
| Q4 24 | 0.31× | — | ||
| Q3 24 | 0.23× | — | ||
| Q2 24 | 0.22× | — | ||
| Q1 24 | 0.21× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $27.7M | $25.8M |
| 自由现金流经营现金流 - 资本支出 | $16.8M | $25.6M |
| 自由现金流率自由现金流/营收 | 7.6% | 15.7% |
| 资本支出强度资本支出/营收 | 4.9% | 0.1% |
| 现金转化率经营现金流/净利润 | — | 25.79× |
| 过去12个月自由现金流最近4个季度 | $-1.3M | $95.6M |
8季度趋势，按日历期对齐
经营现金流OFIXOS
| Q4 25 | $27.7M | $25.8M | ||
| Q3 25 | $12.4M | $5.0M | ||
| Q2 25 | $11.6M | $29.7M | ||
| Q1 25 | $-18.4M | $36.2M | ||
| Q4 24 | $23.7M | — | ||
| Q3 24 | $11.7M | $2.4M | ||
| Q2 24 | $9.0M | $8.1M | ||
| Q1 24 | $-18.6M | $25.5M |
自由现金流OFIXOS
| Q4 25 | $16.8M | $25.6M | ||
| Q3 25 | $2.5M | $4.8M | ||
| Q2 25 | $4.5M | $29.4M | ||
| Q1 25 | $-25.1M | $35.8M | ||
| Q4 24 | $15.2M | — | ||
| Q3 24 | $6.3M | $1.3M | ||
| Q2 24 | $-360.0K | $7.7M | ||
| Q1 24 | $-29.1M | $24.9M |
自由现金流率OFIXOS
| Q4 25 | 7.6% | 15.7% | ||
| Q3 25 | 1.2% | 3.1% | ||
| Q2 25 | 2.2% | 19.9% | ||
| Q1 25 | -13.0% | 26.3% | ||
| Q4 24 | 7.0% | — | ||
| Q3 24 | 3.2% | 1.0% | ||
| Q2 24 | -0.2% | 6.6% | ||
| Q1 24 | -15.4% | 22.5% |
资本支出强度OFIXOS
| Q4 25 | 4.9% | 0.1% | ||
| Q3 25 | 4.8% | 0.1% | ||
| Q2 25 | 3.5% | 0.2% | ||
| Q1 25 | 3.5% | 0.3% | ||
| Q4 24 | 4.0% | — | ||
| Q3 24 | 2.7% | 0.8% | ||
| Q2 24 | 4.7% | 0.3% | ||
| Q1 24 | 5.6% | 0.6% |
现金转化率OFIXOS
| Q4 25 | — | 25.79× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
OS
| Subscription And Circulation | $150.3M | 92% |
| Professional Services And Other | $9.4M | 6% |
| License | $4.0M | 2% |
